Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Novartis
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients diagnosed with metastatic melanoma (C43) during 01 January 2014 and 31 December 2021.
Adult (18 years or older) at the time of diagnosis of metastatic melanoma.
Resident in the corresponding hospital district(s) at the time of diagnosis of metastatic melanoma.
You may not be if
Metastasis recorded prior to 01 January 2014 (i.e. prevalent case).
Record of any other cancer (The International Classification of Diseases, 10th Revision \[ICD-10\] diagnosis code starting with C, excluding C43, C77, C78, and C79) as last cancer diagnosis before metastasis.
Participated in COBRA (vemurafenib, temozolomide, lomustine, vincristine) trial.
